前列腺癌择区淋巴结覆盖的代价:盆腔0、45或54 Gy放疗的晚期生活质量结局与剂量学分析
本研究纳入428例前列腺癌患者(根治性放疗267例、前列腺切除术后放疗160例),按盆腔淋巴结放疗(PLNRT)剂量0、45或54 Gy分组,比较放疗后20-36个月EPIC生活质量评分变化。结果显示54 Gy PLNRT与泌尿功能、尿失禁及总体评分下降显著相关,45 Gy则无此关联,两种剂量均未显著影响肠道生活质量。
要点
- 54 Gy PLNRT组泌尿功能、尿失禁及总体评分达到最小重要差异(MID)下降的频率显著更高。
- 45 Gy PLNRT组未观察到泌尿功能下降的相关性。
- 两种剂量PLNRT均未显著影响肠道子量表或总体评分下降。
核心结论
- 常规分割下,PLNRT加量至54 Gy(而非45 Gy)与更差的泌尿生活质量相关,术后患者下降更陡。
- 两种剂量的PLNRT对肠道生活质量均无显著影响。
研究设计与样本
- 前列腺癌患者(n=428)在根治性放疗(n=267)或前列腺切除术后放疗(n=160)前记录EPIC基线评分。
- PLNRT若给予,处方剂量为45或54 Gy,每次1.8 Gy。
- 放疗后20-36个月记录新的EPIC评分,计算各领域子量表及汇总评分的绝对变化及是否达到MID标准,并对每个指标进行多因素分析(MVA)及后续剂量学分析。
主要发现
- 54 Gy PLNRT组泌尿功能、尿失禁及总体评分达到MID下降的频率显著更高;45 Gy PLNRT组未观察到泌尿功能下降的相关性。
- 在一个或两个MVA模型中,54 Gy PLNRT与泌尿功能、烦恼、刺激症状、尿失禁及总体评分下降显著相关,而45 Gy则不相关。
- 术后状态与泌尿功能、尿失禁及总体评分下降显著相关;在术后患者中,挽救性放疗场景下泌尿功能评分下降显著更大。
- 54 Gy和45 Gy PLNRT均未显著影响肠道子量表或总体评分的下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Elective pelvic lymph node radiotherapy (PLNRT) in prostate cancer is often omitted from definitive (n = 267) and post prostatectomy (n = 160) radiotherapy (RT) due to concerns regarding toxicity and efficacy. Data comparing patient-reported outcome measures (PROMs) with or without PLNRT is limited. Our long-term supposition is that PLNRT, particularly to higher doses afforded by IMRT, will decrease pelvic failure rate in select patients. We aim to establish the impact of two different PLNRT doses on long term quality of life (QOL). METHODS AND MATERIALS: Prostate cancer patients (n = 428) recorded baseline scores using the Expanded Prostate Cancer Index Composite (EPIC), prior to definitive or post-prostatectomy RT. PLNRT, if given, was prescribed to 45 or 54 Gy at 1.8 Gy per fraction. New EPIC scores were recorded 20-36 months after radiotherapy. Absolute change in each domain subscale and summary score was recorded, along with if these changes met minimally important difference (MID) criteria. A separate multivariate analysis (MVA) was performed for each measure. Subsequent dosimetric analysis was performed. RESULTS: Frequency of a MID decline was significantly greater with PLNRT to 54 Gy for urinary function, incontinence, and overall. No urinary decline was correlated with PLNRT to 45 Gy. PLNRT to 54 Gy was significant for decline in urinary function, bother, irritative, incontinence, and overall score in one or both MVA models while 45 Gy was not. Postoperative status was significant for decline in urinary function, incontinence, and overall. Amongst postoperative patients, there was significantly greater decline in urinary function score in the salvage setting. Neither 54 nor 45 Gy significantly affected bowel subscale or overall score decline. CONCLUSIONS: Using conventional fractionation, adding PLNRT to 54 Gy, but not 45 Gy, correlates with worse urinary QOL, with postoperative patients experiencing a steeper decline. PLNRT had no significant impact on bowel QOL with either dose.
引用
- Jensen GL, Jhavar SG, Ha CS, et al. The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis. Clin Transl Radiat Oncol. 2022. PMID: 35813937. doi:10.1016/j.ctro.2022.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。